Exploring homologous recombination deficiency thresholds for predicting response to platinum-based treatment in triple negative breast cancer.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Kirsten Timms, Lauren Lenz, Elizabeth S. Cogan, Erica L. Mayer, Virginia G. Kaklamani, Vered Stearns, Vandana G Abramson, Carla Isadora Falkson, Rachel Catherine Jankowitz, P. Kelly Kelly Marcom, Nadine M. Tung, William John Gradishar, James M. Ford, Shaveta Vinayak, Judy Caroline Boughey, Matthew P. Goetz, Anna Maria Storniolo, Roisin M. Connolly, Andrea L. Richardson, Melinda L. Telli
Institutions: Myriad Genetics, Dana-Farber Cancer Institute, Johns Hopkins University, Vanderbilt University, Vanderbilt-Ingram Cancer Center, University of Rochester Medicine, University of Pittsburgh Medical Center, Duke Medical Center, Duke Cancer Institute, Beth Israel Deaconess Medical Center, Northwestern University, Stanford Medicine, Stanford University, University of Washington, Mayo Clinic, Indiana University Health, Indiana University Indianapolis, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, University College Cork, Sidney Kimmel Comprehensive Cancer Center
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4286299162